Piromelatine
id:
piromelatine-186-16351777
title:
Piromelatine
text:
Piromelatine (Neu-P11) is a multimodal sleep drug under development by Neurim Pharmaceuticals. It is an agonist at melatonin MT1/MT2 and serotonin 5-HT1A/5-HT1D receptors. Neurim is conducting a phase II randomized, placebo controlled trial of cognitive and sleep effects in Alzheimer's disease. Results of a phase II trial on insomnia in 120 adults were announced in 2013, finding piromelatine 20/50 mg improved sleep over 4 weeks vs placebo. Phase 1A/1B studies in 2011, showed safe dose-dependent
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Piromelatine
date created:
2014-10-24T20:29:26Z
date modified:
2024-09-08T03:27:52Z
main entity:
{"identifier":"Q18388725","url":"https://www.wikidata.org/entity/Q18388725"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/de/Piromelatine.svg","width":1430,"height":795}
fields total:
13
integrity:
16